Patents Assigned to Picobella, LP
  • Patent number: 7723043
    Abstract: Methods for diagnosing and treating prostate cancer are disclosed. In practicing the method, a subject's body-fluid sample is assayed for GPC3 protein, and the GPC3 level observed is used in determining whether the subject has an elevated GPC3 level associated with prostate cancer. Patients with such elevated levels may be treated, in accordance with the invention, with a variety of GPC3-related immunotherapy agents.
    Type: Grant
    Filed: January 4, 2006
    Date of Patent: May 25, 2010
    Assignee: Picobella, LP
    Inventors: Bruce Wang, Matthias Wabl